Prism Medico and Pharmacy Ltd512217Bank / NBFC

Non Banking Financial Company (NBFC) Latest results: Dec 2019 13 quarters of data

₹29.19

MCap ₹18 Cr

Prism Medico and Pharmacy Ltd — Stock analysis & AI research Prism Medico and Pharmacy Ltd — Live exchange announcements

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹10 Cr

Interest Earned · Dec 2019

-43.1% YoY

—

Operating Profit · Dec 2019

₹-0 Cr

Net Profit · Dec 2019

-126.7% YoY

₹-0.07

EPS · Dec 2019

-128.0% YoY

—

Gross NPA % · Dec 2019

—

Net NPA % · Dec 2019

📝 Prism Medico and Pharmacy Ltd — results explained

Quarter ended December 2019 (Q3 FY20)

Prism Medico and Pharmacy Ltd reported total income of ₹10 crore for the quarter ended December 2019 (Q3 FY20), down 42.9% from ₹17 crore in the same quarter last year, and up 47.5% sequentially over the September 2019 quarter.

Of this, interest earned contributed ₹10 crore and other income ₹0 crore. Net interest income (interest earned minus interest expended of ₹0 crore) worked out to ₹10 crore.

The company reported a net loss of ₹0 crore, against a net profit of ₹0 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.07.

Full year and trailing twelve months

For the full year FY20, Prism Medico and Pharmacy Ltd posted total income of ₹25 crore, a decline of 54.2% over FY19, with a net profit of ₹0 crore (up 157.1% year-on-year).

On a trailing-twelve-month (TTM) basis, total income stands at ₹42 crore with a net loss of ₹1 crore.

Valuation snapshot

At the current price of ₹29.19, 512217 has a market capitalisation of ₹18 crore.

Within the Non Banking Financial Company (NBFC) industry, it is the 25th-largest of the 224 companies we track by market value.

Shareholding pattern

As of May 2026, promoters held 30.20%, public shareholders 69.80% of Prism Medico and Pharmacy Ltd.

Promoter holding rose from 25.50% to 30.20% over the latest period.

📈 Share price & events

📊 Quarterly trend

₹ crore

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹18 Cr

Current Price ?

₹29.2

P/E ?

N/A

Industry P/E ?

22.40

P/B ?

1.15

P/S ?

0.42

P/FCF ?

N/A

Enterprise Value ?

N/A

EV/EBITDA ?

N/A

PEG ?

N/A

Earnings Yield ?

-3.1%

Dividend Yield ?

0.00%

Profitability & Returns

Total Income (TTM) ?

₹42 Cr

OPM ?

N/A

Profit after tax (TTM) ?

₹-1 Cr

EPS (TTM) ?

₹-0.91

ROCE ?

N/A

ROE ?

-3.6%

ROA ?

-3.5%

Gross NPA % ?

N/A

Net NPA % ?

N/A

Growth

Total Income — latest qtr ?

₹10 Cr

PAT — latest qtr ?

₹-0 Cr

YoY qtr sales growth ?

-42.9%

YoY qtr profit growth ?

-126.7%

Sales growth (3y) ?

N/A

Sales growth (5y) ?

N/A

Profit growth (3y) ?

N/A

Profit growth (5y) ?

N/A

Financial Health

Debt ?

N/A

Debt to Equity ?

N/A

Interest Coverage ?

N/A

Current Ratio ?

N/A

Ownership

Promoter holding ?

30.20%

Change in promoter holding ?

5.20%

Pledged percentage ?

N/A

Market

Return 3 months ?

8.2%

Return 6 months ?

12.1%

🗓️ Quarterly results (13 quarters · ₹ Cr)

same fiscal quarter as Dec bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Jun 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	YoY %	QoQ %
Interest Earned	0	2	12	6	5	0	6	15	17	17	9	7	10	-43.1%	+47.1%
Other Income	0	0	0	0	0	0	0	0	0	0	0	0	0	—	—
Total Income	0	3	12	6	5	0	6	15	17	17	9	7	10	-42.9%	+47.5%
Interest Expended	0	0	0	0	0	0	0	0	0	0	0	0	0	+133.3%	+0.0%
Operating Profit	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Provisions	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Before Tax	-0	1	1	-0	-0	-0	0	0	0	-1	0	0	-0	-128.6%	-150.0%
Net Profit	-0	1	1	-0	-0	-0	0	0	0	-1	0	0	-0	-126.7%	-144.4%
EPS	-0.55	0.91	1.12	-0.23	-0.20	-0.69	0.61	0.46	0.25	-1.20	0.21	0.15	-0.07	-128.0%	-146.7%
Gross NPA %	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net NPA %	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Capital Adequacy Ratio	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric	FY19	FY20	TTM	YoY %
Interest Earned	₹55 Cr	₹25 Cr	₹42 Cr	-54.1%
Other Income	₹0 Cr	₹0 Cr	₹0 Cr	-80.0%
Total Income	₹55 Cr	₹25 Cr	₹42 Cr	-54.2%
Interest Expended	₹0 Cr	₹0 Cr	₹0 Cr	+27.3%
Net Interest Income	₹55 Cr	₹25 Cr	₹42 Cr	-54.3%
Operating Profit	—	—	—	—
Provisions	—	—	—	—
Profit Before Tax	₹0 Cr	₹0 Cr	₹-1 Cr	+100.0%
Tax	—	—	—	—
Net Profit	₹0 Cr	₹0 Cr	₹-1 Cr	+157.1%
EPS	₹0.12	₹0.29	₹-0.91	+141.7%

🏛️ Balance Sheet (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Equity Capital	6.06	6.06	6.06	6.06	+0.0%
Reserves	9.10	9.08	9.03	9.35	+3.5%
Borrowing	0.00	0.00	0.00	0.00	—
Other Liabilities	0.23	0.10	0.47	0.20	-57.4%
Total Liabilities	15.39	15.24	15.56	15.61	+0.3%
Fixed Assets	0.03	0.03	0.03	0.03	+0.0%
CWIP	0.00	0.00	0.00	0.00	—
Investments	0.00	0.00	0.00	0.00	—
Other Assets	15.36	15.21	15.53	15.58	+0.3%
Total Assets	15.39	15.24	15.56	15.61	+0.3%

💧 Cash Flow (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Cash from Operating Activity	2.95	-0.01	-0.02	0.00	+100.0%
Cash from Investing Activity	-2.91	0.00	0.00	0.00	—
Cash from Financing Activity	0.00	-0.01	0.00	0.00	—
Net Cash Flow	0.04	-0.01	-0.02	0.00	+100.0%
Free Cash Flow	2.95	-0.01	-0.02	0.00	+100.0%
CFO/OP	-3,220%	8%	25%	0%	-100.0%

➗ Ratios (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
ROE %	-0.58%	-0.13%	-0.33%	2.10%	+736.4%

👥 Shareholding (latest 4 periods)

Metric	Sep 2025	Dec 2025	Mar 2026	May 2026	% Chg
Promoters	25.00%	25.00%	25.50%	30.20%	+18.4%
Public	75.00%	75.01%	74.51%	69.80%	-6.3%
No. of Shareholders	4,315	4,306	4,295	4,300	+0.1%

⚖️ Peer comparison

Industry: Non Banking Financial Company (NBFC) · top 25 of 224 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Total Inc TTM	NP TTM	OPM%	NPM%	Inc YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	533095 Bengal & Assam	₹6,230.50	6,740	9.2	2,542	783	3.7%	30.8%	10.9%	11.8%	9.7%	-23.8%
2	512065 Mrugesh Trading	₹4.63	5,543	—	13	-0	0.7%	-1.4%	-38.7%	-191.4%	—	273.2%
3	SGFIN SG Finserve	₹694.90	4,579	24.4	488	187	16.8%	38.3%	94.2%	56.8%	114.7%	110.0%
4	501945 Dhenu Buildcon	₹2.50	3,234	—	1	-1	132.6%	-87.9%	-300.0%	-293.9%	283.9%	181.2%
5	543766 Ashika Global	₹474.05	2,821	57.6	163	61	72.6%	37.3%	145.5%	163.6%	78.3%	77.9%
6	523862 Grand Oak	₹41.75	1,787	—	245	0	-0.0%	0.0%	3081.3%	195.7%	4905.7%	-100.6%
7	532485 Balmer Lawrie	₹71.12	1,441	8.8	2,794	282	13.5%	10.1%	7.9%	4.1%	10.0%	5.2%
8	530499 AK Capital	₹1,690.30	1,158	9.7	578	118	7.1%	20.5%	18.2%	31.0%	4.7%	17.8%
9	512020 Saraswati Commercial	₹12,132.00	1,079	10.0	166	133	44.9%	80.1%	61.3%	75.5%	143.8%	164.8%
10	511628 Fedders Holding	₹42.34	1,025	9.9	443	86	2.3%	19.4%	-1.1%	139.5%	-9.4%	-32.4%
11	CIFL Capital India	₹21.75	851	97.3	532	27	4.5%	5.1%	—	—	4.2%	-70.7%
12	530245 Aryaman Financial	₹363.90	778	11.4	75	39	22.5%	51.8%	-28.5%	-15.6%	-30.2%	6.6%
13	535667 India Finsec	₹135.95	730	17.1	97	23	9.7%	24.0%	19.7%	19.9%	56.6%	28.4%
14	511702 Yogi	₹46.27	696	15.3	399	13	-0.3%	3.3%	289.7%	1293.8%	-45.6%	-113.6%
15	LAXMIINDIA Laxmi India	₹125.71	659	11.6	341	57	17.7%	16.6%	—	—	33.6%	65.7%
16	537750 Kiran Vyapar	₹197.57	527	84.6	112	6	14.8%	5.8%	-18.2%	-94.9%	0.2%	21.6%
17	538772 538772	—	507	—	301	-3	-2.0%	-0.9%	3.6%	102.2%	-22.5%	-169.2%
18	541358 Unifinz Capital	₹203.55	444	10.3	609	87	3.8%	14.3%	319.7%	335.0%	117.3%	2.1%
19	544191 Purple Finance	₹76.66	403	—	58	-1	0.7%	-2.1%	222.1%	58.6%	162.5%	107.9%
20	512399 Sera Investments	₹22.22	398	1.4	128	103	45.7%	80.2%	554.5%	1666.7%	1865.3%	—
21	538476 538476	—	368	—	26	3	17.9%	12.1%	-11.1%	-57.0%	10.7%	17.7%
22	MONEYBOXX Moneyboxx Finance	₹48.65	340	256.1	225	1	10.6%	0.6%	—	—	-11.9%	-13.8%
23	531652 UVS Hospitality	₹147.10	287	—	2	-4	0.0%	-177.7%	117.8%	30.7%	9.1%	24.1%
24	CPCAP CP Capital	₹153.11	279	6.1	76	44	26.5%	58.3%	—	—	46.3%	21.0%
25	512217 Prism Medico	₹27.17	18	—	42	-1	0.0%	-1.3%	-54.2%	157.1%	-42.9%	-126.7%

❓ Frequently asked questions

What was Prism Medico and Pharmacy Ltd's total income in Q3 FY20?

What was Prism Medico and Pharmacy Ltd's net profit in Q3 FY20?